المؤلفون: Stefan Schnabel, Christian Mawrin, Felix Sahm, Natalie Waldt, Christoph Kesseler, Josephine Liebich, Peter John, C. Scherlach, Frank Angenstein, I. Erol Sandalcioglu, Elmar Kirches

المصدر: Neuropathology & applied neurobiology 48(2), e12780 (2022). doi:10.1111/nan.12780

مصطلحات موضوعية: Histology, pathology [Meningeal Neoplasms], Cell, pharmacology [Enzyme Inhibitors], AKT1, Biology, medicine.disease_cause, meningioma, Pathology and Forensic Medicine, pharmacology [Pyrimidines], Meningioma, Mice, capivasertib, In vivo, Cell Line, Tumor, antagonists & inhibitors [Proto-Oncogene Proteins c-akt], pathology [Skull Base Neoplasms], Physiology (medical), otorhinolaryngologic diseases, medicine, Animals, Humans, Pyrroles, ddc:610, Enzyme Inhibitors, neoplasms, drug effects [Cell Proliferation], Mutation, genetics [Meningeal Neoplasms], Akt inhibitor AZD5363, Cell growth, genetics [Meningioma], targeted therapy, medicine.disease, nervous system diseases, Pyrimidines, medicine.anatomical_structure, Neurology, Cell culture, Cancer research, pharmacology [Pyrroles], genetics [Proto-Oncogene Proteins c-akt], genetics [Skull Base Neoplasms], Neurology (clinical), Proto-Oncogene Proteins c-akt, pathology [Meningioma]

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cca490852d8aecdd9a5e8a3886f1d3a
https://doi.org/10.1111/nan.12780